Metabolic Symbiosis: Lactate as an Epigenetic Regulator and a Biofuel in Age-dependent Intervertebral Disc Degeneration
代谢共生:乳酸作为年龄依赖性椎间盘退变的表观遗传调节剂和生物燃料
基本信息
- 批准号:10704160
- 负责人:
- 金额:$ 40.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcetylationAerobicAgeBack PainBioenergeticsBioinformaticsBiological AssayCarbonCell Culture TechniquesCell SeparationCell SurvivalCell physiologyCellsChemicalsChromatinChromatin StructureDNADataDegenerative DisorderDevelopmentDiffusionDiseaseEconomic BurdenEnvironmentEnzyme Inhibitor DrugsEnzymesEpigenetic ProcessFemaleFoundationsFutureGene ExpressionGene Expression RegulationGenesGeneticGlucoseGlycolysisHistonesHomeostasisHumanHypoxiaInjectionsInterruptionIntervertebral disc structureKnock-outLactic acidLinkLow Back PainLysineMacrophageMeasuresMetabolicMetabolismModelingMolecularMusNutrientOrganOxidative PhosphorylationOxygenPathway interactionsPatternPeripheralPhenotypePost-Translational Protein ProcessingPublic HealthRattusReportingResearchRoleSourceSpinal DiseasesSymbiosisTamoxifenTestingTissuesTranscriptional RegulationTransgenic MiceVertebral columnWaste Productsage relatedanaerobic glycolysischromatin immunoprecipitationchronic back paincostdeep sequencingdisabilityextracellularinnovationintervertebral disk degenerationmalemouse modelnew therapeutic targetnovelnucleus pulposusnutritionpreventregenerativesocioeconomicssuccesstherapeutic targettissue culturetranscriptome sequencinguptakewasting
项目摘要
Project Summary
Intervertebral disc degeneration (IDD) underlies many spinal disorders and results in debilitating
back pain, disability, and tremendous socioeconomic burden. The intervertebral disc (IVD) is the
largest avascular organ comprised of a hypoxic nucleus pulposus (NP) center surrounded by an
outer, more oxygenated annulus fibrosus (AF). The IVD contains copious amounts of lactic acid,
which has long been viewed as a harmful waste byproduct of anaerobic glycolysis in the NP.
However, we recently made two major advances that challenge this longstanding dogma. We
demonstrated that AF cells can take up and utilize lactate as a carbon source via oxidative
phosphorylation (OXPHOS), thus unveiling lactate-dependent metabolic symbiosis between NP
and AF whereby the hypoxic NP cells make lactate to be used by the more aerobic AF cells as
a carbon biofuel via OXPHOS. We also discovered high levels of IVD histone lactylation, a
newly characterized type of histone post-translational modification (PTM) that uses lactate as a
substrate precursor. Histone PTMs are critical to the dynamic modulation of chromatin structure
and gene expression, and dysregulation of histone PTMs is closely linked with the development
of many diseases. Based on our preliminary data, we hypothesize that disc lactate is not as
a waste byproduct but rather serves as an important biofuel for the nutrient-poor disc
and as a vital metabolic regulator of disc gene expression programming via histone
lactylation. We propose three specific aims to test this hypothesis: (1) Determine whether
lactate functions as an important metabolic regulator of disc gene expression through histone
lactylation using rat disc cell culture models treated with chemical inhibitors of enzymes
responsible for histone lactylation; (2) Determine whether disc histone lactylation and lactate-
dependent metabolic symbiosis malfunction with age contributing to age-related IDD using
young and old Fischer 344 rats; and (3) Determine whether interrupted disc lactate-dependent
metabolic symbiosis disrupts disc histone lactylation pattern and promotes IDD using transgenic
mouse models with AF-targeted genetic depletion to disrupt AF lactate uptake. Completion of
the proposed studies will establish whether histone lactylation exerts epigenetic transcription
regulation that controls disc matrix homeostasis and lactate-dependent metabolic symbiosis.
Demonstrating the influences of lactate metabolism on age-related IDD through the
mechanisms of epigenetic gene regulation and lactate-dependent metabolic symbiosis will be
both novel and significant to identify new therapeutic targets to treat IDD with greater likelihood
of success in the nutrient poor environment. This will be an innovative approach and significant
advance over prior regenerative efforts which have had limited success in this unique tissue.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gwendolyn A Sowa其他文献
Gwendolyn A Sowa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gwendolyn A Sowa', 18)}}的其他基金
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
10415626 - 财政年份:2021
- 资助金额:
$ 40.8万 - 项目类别:
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
10406064 - 财政年份:2021
- 资助金额:
$ 40.8万 - 项目类别:
Influence of inflammation-related genetic variants on PT treatment response in a population affected by CLBP
CLBP 人群中炎症相关基因变异对 PT 治疗反应的影响
- 批准号:
10208162 - 财政年份:2019
- 资助金额:
$ 40.8万 - 项目类别:
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
10765802 - 财政年份:2019
- 资助金额:
$ 40.8万 - 项目类别:
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
9897962 - 财政年份:2019
- 资助金额:
$ 40.8万 - 项目类别:
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
10765803 - 财政年份:2019
- 资助金额:
$ 40.8万 - 项目类别:
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P:分析生物力学、生物和行为表型
- 批准号:
9897963 - 财政年份:2019
- 资助金额:
$ 40.8万 - 项目类别:
Alternative treatments for disc degeneration: Effects on matrix homeostasis
椎间盘退变的替代治疗:对基质稳态的影响
- 批准号:
8411092 - 财政年份:2009
- 资助金额:
$ 40.8万 - 项目类别:
Alternative treatments for disc degeneration: Effects on matrix homeostasis
椎间盘退变的替代治疗:对基质稳态的影响
- 批准号:
7806660 - 财政年份:2009
- 资助金额:
$ 40.8万 - 项目类别:
INVESTIGATION INTO THE MECHANISM OF SYMPTOM RELIEF WITH FORWARD FLEXION IN OLDER
老年人前屈症状缓解机制的探讨
- 批准号:
7930032 - 财政年份:2009
- 资助金额:
$ 40.8万 - 项目类别:
相似海外基金
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
- 批准号:
23K07830 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing Late Metal Catalytic Systems for Aerobic Partial Oxidation of Alkanes
开发烷烃有氧部分氧化的后金属催化系统
- 批准号:
2247667 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Standard Grant
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses
阿尔茨海默病的精准医学:使用 AT(N) 生物标志物优化有氧健身反应的适应性运动及其作用机制的 SMART 试验
- 批准号:
10581973 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
- 批准号:
10585366 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Investigating the physical and chemical controls on aerobic methane oxidation
研究好氧甲烷氧化的物理和化学控制
- 批准号:
2241873 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Standard Grant
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除;
- 批准号:
485524 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Operating Grants
Effect of aerobic exercise-induced sleep changes on arterial stiffness associated with postprandial hyperglycemia.
有氧运动引起的睡眠变化对与餐后高血糖相关的动脉僵硬度的影响。
- 批准号:
23K10645 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:
10717825 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:
The Effects of Aerobic Exercise on Cardiovascular Health in Postmenopausal Females: A Systematic Review and Meta-Analysis
有氧运动对绝经后女性心血管健康的影响:系统评价和荟萃分析
- 批准号:
480729 - 财政年份:2023
- 资助金额:
$ 40.8万 - 项目类别:














{{item.name}}会员




